Ivan Herrera
Overview
Explore the profile of Ivan Herrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herrera I, Almenara S, Bellot P, Miralles C, Rodriguez M, Gomez-Gonzalez L, et al.
J Clin Exp Hepatol
. 2024 Aug;
14(6):101472.
PMID: 39100888
Background & Aims: This study aims to assess the incidence and characteristics of all cancers, hepatocellular carcinoma (HCC), and extrahepatic cancers in patients with cirrhosis of various etiologies. Methods: Prospective...
2.
Martinez-Moreno B, Martinez Martinez J, Herrera I, Guilabert L, Rodriguez-Soler M, Bellot P, et al.
Endoscopy
. 2024 Jul;
57(1):62-67.
PMID: 39025130
Background: Hepatic venous portal gradient (HVPG) measurement remains the gold standard for estimating portal pressure gradient (PPG). This study aimed to evaluate the correlation between endoscopic ultrasound (EUS)-guided PPG and...
3.
Almenara S, Lozano-Ruiz B, Herrera I, Gimenez P, Miralles C, Bellot P, et al.
Biomed Pharmacother
. 2023 May;
163:114885.
PMID: 37201262
Background: Treatment with non-selective beta-blockers (NSBB) has been associated with anti-inflammatory and anti-cancer effects in patients with cirrhosis. This study aims to analyze the impact of chronic NSBB treatment on...
4.
Almenara S, Lozano B, Gimenez P, Herrera I, Miralles C, Bellot P, et al.
Hepatol Int
. 2020 Sep;
14(5):858-868.
PMID: 32885366
Background: In patients with cirrhosis, beta-adrenoceptors expressed on peripheral blood mononuclear cells have a reduced response to catecholamine stimulation. This study aimed to determine if chronic treatment with beta-blockers influences...
5.
Herrera I, Pascual S, Zapater P, Carnicer F, Bellot P, Palazon J
Eur J Gastroenterol Hepatol
. 2016 Jun;
28(10):1194-7.
PMID: 27294486
Introduction: Patients with cirrhosis by hepatitis C virus infection treated with β-blockers (BB) have been shown to have a reduced incidence of hepatocellular carcinoma (HCC). Also, an association between propranolol...
6.
Pascual S, Herrera I, Irurzun J
World J Hepatol
. 2016 Mar;
8(9):421-38.
PMID: 27028578
Hepatocellular carcinoma (HCC) is the leading cause of deaths in cirrhotic patients and the third cause of cancer related deaths. Most HCC are associated with well known underlying risk factors,...
7.
Herrera I, Leiva-Salinas M, Palazon J, Pascual J, Niveiro M
Gastroenterol Hepatol
. 2014 May;
38(1):12-3.
PMID: 24837003
No abstract available.